October 1 Product Theatres
- 10am – Sponsored by Eli Lilly
- 12:15pm – Sponsored by Eisai
Evolving Role of Precision Oncology in Managing RET-altered Thyroid Cancer
Join an expert faculty discussion on the best practices in diagnosis and the utilization of biomarkers to optimize treatment selection.
First Speaker – Bryan McIver MD PhD FRCP (Edin)
Deputy Physician in Chief
Moffitt Cancer Center
Second Speaker – Marcia S Brose MD PhD FASCO
Chief of Cancer Services, Sidney Kimmel Cancer Center-Jefferson Health
Chair of Hematology/Oncology, Torresdale Hospital
Lenvima: A Treatment for Patients with Locally Recurrent or Metastatic, Progressive, Radioactive Iodine-Refractory Differentiated Thyroid Cancer
Speaker – Ezra Cohen, MD, FRCPSC, FASCO
There are outstanding opportunities for industry participation. For more details on the available sponsorship and exhibitor options, please contact:
| Rebecca Darling, rebecca@bayleygroup.com Call: +1. 519.263.5050 / +1. 519.263.6001 (direct) Toll Free: 1.888.527.3434 (North America only) |
| Cass Bayley cass@bayleygroup.com Call: +1. 519.263.5050 / +1. 519.263.6000 (direct) Toll Free: 1.888.527.3434 (North America only) |